Southpoint Capital Advisors LP 10x Genomics, Inc. Transaction History

Southpoint Capital Advisors LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$19.45 - $37.37 $5.84 Million - $11.2 Million	-300,000 Reduced 42.86%	400,000 $7.78 Million
Q1 2024 May 15, 2024	BUY	$36.08 - $54.3 $25.3 Million - $38 Million	700,000 New	700,000 $26.3 Million
Q4 2022 Feb 14, 2023	BUY	$24.4 - $41.3 $7.32 Million - $12.4 Million	300,000 New	300,000 $10.9 Million

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Southpoint Capital Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Southpoint Capital Advisors LP with notifications on news.